Paper · 36010993
The Extracellular Matrix: A Key Accomplice of Cancer Stem Cell Migration, Metastasis Formation, and Drug Resistance in PDAC.
Wang D and 5 others. Cancers (Basel), 2022. Cited by 68 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The Extracellular Matrix: A Key Accomplice of Cancer Stem Cell Migration, Metastasis Formation, and Drug Resistance in PDAC. Papers, record 36010993. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36010993
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Extracellular Matrix: A Key Accomplice of Cancer Stem Cell Migration, Metastasis Formation, and Drug Resistance in PDAC.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References205
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25,146,937 | Human lysyl oxidase-like 2. | Bioorg Chem | 2014 | https://conductscience.org/library/papers/25146937 | PubMed |
| 2 | 28,685,754 | Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions. | Nat Commun | 2017 | https://conductscience.org/library/papers/28685754 | PubMed |
| 3 | 27,317,748 | Tumor-associated fibroblasts predominantly come from local and not circulating precursors. | Proc Natl Acad Sci U S A | 2016 | https://conductscience.org/library/papers/27317748 | PubMed |
| 4 | 26,390,428 | A Phase I Study of FOLFIRINOX Plus IPI-926, a Hedgehog Pathway Inhibitor, for Advanced Pancreatic Adenocarcinoma. | Pancreas | 2016 | https://conductscience.org/library/papers/26390428 | PubMed |
| 5 | 20,627,072 | Tumors as organs: complex tissues that interface with the entire organism. | Dev Cell | 2010 | https://conductscience.org/library/papers/20627072 | PubMed |
| 6 | 1,644,063 | Hyaluronan is a secretory product of human pancreatic adenocarcinoma cells. | Eur J Cell Biol | 1992 | https://conductscience.org/library/papers/1644063 | PubMed |
| 7 | 23,108,409 | Efficient TGFβ-induced epithelial-mesenchymal transition depends on hyaluronan synthase HAS2. | Oncogene | 2013 | https://conductscience.org/library/papers/23108409 | PubMed |
| 8 | 31,063,753 | The Extracellular Matrix Modulates the Metastatic Journey. | Dev Cell | 2019 | https://conductscience.org/library/papers/31063753 | PubMed |
| 9 | 29,673,760 | Tumor-suppressive functions of 4-MU on breast cancer cells of different ER status: Regulation of hyaluronan/HAS2/CD44 and specific matrix effectors. | Matrix Biol | 2019 | https://conductscience.org/library/papers/29673760 | PubMed |
| 10 | 27,821,172 | A positive feedback loop involving the Wnt/β-catenin/MYC/Sox2 axis defines a highly tumorigenic cell subpopulation in ALK-positive anaplastic large cell lymphoma. | J Hematol Oncol | 2016 | https://conductscience.org/library/papers/27821172 | PubMed |
1 to 10 of 205
See all 205 referencesCited by49
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,979,040 | Naringenin in pancreatic cancer: emerging evidence on the tumor immune-stromal microenvironment, immunometabolic reprogramming, microbiota-host crosstalk, and therapeutic resistance. | Front Immunol | 2026 | https://conductscience.org/library/papers/42979040 | PubMed |
| 42,922,696 | Exploring the interaction between extracellular matrix components of bone marrow and prostate cancer cells in a novel 3D model. | Res Sq | 2026 | https://conductscience.org/library/papers/42922696 | PubMed |
| 42,512,419 | Cancer-Associated Fibroblast Heterogeneity and Extracellular Matrix Remodeling as Orchestrators of Drug Resistance in Upper Gastrointestinal Cancers: Insights from Spatial Multi-Omics and Therapeutic Implications. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42512419 | PubMed |
| 42,364,974 | Integrated scRNA-Seq and functional profiling reveal CD52 as a driver of pancreatic ductal adenocarcinoma metastasis and immunosuppression. | Oncogenesis | 2026 | https://conductscience.org/library/papers/42364974 | PubMed |
| 42,352,435 | MMPs' Impact on Carcinogenesis in Specific Organs and Systems. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42352435 | PubMed |
| 42,073,517 | Ensemble Machine Learning Predicts Platinum Resistance in Ovarian Cancer Using Laboratory Data. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42073517 | PubMed |
| 42,055,627 | Proximity Mapping of the ER Proteome Reveals Metastasis-specific Candidate Biomarkers in Breast Cancer Cell Lines. | Cancer Genomics Proteomics | 2026 | https://conductscience.org/library/papers/42055627 | PubMed |
| 41,799,699 | Dual-transferred atmospheric-pressure plasma jet modulates matrix metalloproteinase expression in breast cancer stem cells. | Biochem Biophys Rep | 2026 | https://conductscience.org/library/papers/41799699 | PubMed |
| 41,692,802 | Matrix stiffness induces Ca2+-DCLK1-PIP5K1A mechanotransduction as a context-specific amplifier in pancreatic cancer progression and chemotherapy resistance. | Exp Hematol Oncol | 2026 | https://conductscience.org/library/papers/41692802 | PubMed |
| 41,566,958 | Dynamic granular hydrogels to assess pancreatic cancer cell fate. | Biomater Sci | 2026 | https://conductscience.org/library/papers/41566958 | PubMed |
1 to 10 of 49
See all 49 cited byGenes56
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABCB1 | 5,243 | PubTator's text mining | https://conductscience.org/library/genes/5243 | NCBI Gene |
| ACTA1 | 58 | PubTator's text mining | https://conductscience.org/library/genes/58 | NCBI Gene |
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| CCL18 | 6,362 | PubTator's text mining | https://conductscience.org/library/genes/6362 | NCBI Gene |
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CD44 | 960 | PubTator's text mining | https://conductscience.org/library/genes/960 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| CDH1 | 999 | PubTator's text mining | https://conductscience.org/library/genes/999 | NCBI Gene |
| CTNNB1 | 1,499 | PubTator's text mining | https://conductscience.org/library/genes/1499 | NCBI Gene |
| ELN | 2,006 | PubTator's text mining | https://conductscience.org/library/genes/2006 | NCBI Gene |
1 to 10 of 56
See all 56 genesDrugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36010993
GET https://conductscience.org/api/papers/v1/36010993/references?page=2